(HealthDay News) — Cannabidiol (CBD) appears safe and may reduce anxiety in patients with advanced breast cancer, according to a study published in JAMA Network Open.

This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.

Many patients with multiple myeloma experience persistent pain and use opioids to manage that pain even after they achieve remission, a survey suggests.

This page includes links to articles highlighting the top hematologic cancer research published on Cancer Therapy Advisor in ...

Source: Getty Images Data presented at SABCS 2024 suggest that certain patients can safely skip sentinel lymph node biopsy, ...

Research presented at ASH 2024 could change the treatment of patients with newly diagnosed and relapsed or refractory MM, ...

(HealthDay News) — The mean body mass index (BMI) and prevalence of obesity declined in the United States in 2023, according to research published in JAMA Health Forum.

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy to treat unresectable or metastatic, HER2-, PD-L1+ gastric or GEJ adenocarcinoma.

Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.

Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.

There is no indication that Luigi Mangione, the man charged with killing UnitedHealthcare CEO Brian Thompson, was ever a client of UnitedHealthcare, according to authorities.

The FDA has approved Ensacove (ensartinib) to treat patients with ALK+ advanced NSCLC who have not previously received an ALK inhibitor.